nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ATP4A—esophageal cancer	0.509	0.885	CbGaD
Pantoprazole—ABCB1—esophageal cancer	0.0664	0.115	CbGaD
Pantoprazole—ABCG2—Carboplatin—esophageal cancer	0.0481	0.219	CbGbCtD
Pantoprazole—ABCG2—Cisplatin—esophageal cancer	0.0411	0.187	CbGbCtD
Pantoprazole—SLCO1B1—Methotrexate—esophageal cancer	0.0336	0.153	CbGbCtD
Pantoprazole—CYP2C9—Capecitabine—esophageal cancer	0.0303	0.138	CbGbCtD
Pantoprazole—ABCG2—Methotrexate—esophageal cancer	0.0267	0.122	CbGbCtD
Pantoprazole—ATP4A—gastric juice—esophageal cancer	0.0251	0.493	CbGeAlD
Pantoprazole—CYP2C9—Cisplatin—esophageal cancer	0.0153	0.0696	CbGbCtD
Pantoprazole—ABCB1—Cisplatin—esophageal cancer	0.0148	0.0675	CbGbCtD
Pantoprazole—ATP4A—larynx—esophageal cancer	0.0111	0.219	CbGeAlD
Pantoprazole—ABCB1—Methotrexate—esophageal cancer	0.00961	0.0438	CbGbCtD
Pantoprazole—ATP4B—digestive system—esophageal cancer	0.00351	0.0691	CbGeAlD
Pantoprazole—ATP4A—neck—esophageal cancer	0.00295	0.0581	CbGeAlD
Pantoprazole—ATP4A—epithelium—esophageal cancer	0.00201	0.0395	CbGeAlD
Pantoprazole—Esomeprazole—ATP4A—esophageal cancer	0.00171	0.285	CrCbGaD
Pantoprazole—ATP4A—digestive system—esophageal cancer	0.00153	0.0301	CbGeAlD
Pantoprazole—Rabeprazole—ATP4A—esophageal cancer	0.00124	0.206	CrCbGaD
Pantoprazole—Omeprazole—ATP4A—esophageal cancer	0.00101	0.168	CrCbGaD
Pantoprazole—Lansoprazole—ATP4A—esophageal cancer	0.000921	0.154	CrCbGaD
Pantoprazole—SLCO1B1—digestive system—esophageal cancer	0.00082	0.0161	CbGeAlD
Pantoprazole—CYP2C19—digestive system—esophageal cancer	0.000534	0.0105	CbGeAlD
Pantoprazole—Omeprazole—CYP1B1—esophageal cancer	0.000457	0.0762	CrCbGaD
Pantoprazole—CYP1A2—digestive system—esophageal cancer	0.000436	0.00858	CbGeAlD
Pantoprazole—Lansoprazole—CYP1B1—esophageal cancer	0.000418	0.0697	CrCbGaD
Pantoprazole—CYP2C9—digestive system—esophageal cancer	0.000414	0.00815	CbGeAlD
Pantoprazole—ABCG2—lung—esophageal cancer	0.000379	0.00745	CbGeAlD
Pantoprazole—CYP1A2—lung—esophageal cancer	0.000364	0.00717	CbGeAlD
Pantoprazole—CYP3A4—digestive system—esophageal cancer	0.000316	0.00621	CbGeAlD
Pantoprazole—ABCB1—epithelium—esophageal cancer	0.000294	0.00578	CbGeAlD
Pantoprazole—ABCB1—trachea—esophageal cancer	0.00026	0.00511	CbGeAlD
Pantoprazole—ABCG2—lymph node—esophageal cancer	0.000259	0.00509	CbGeAlD
Pantoprazole—ABCB1—digestive system—esophageal cancer	0.000224	0.0044	CbGeAlD
Pantoprazole—ABCB1—lung—esophageal cancer	0.000187	0.00367	CbGeAlD
Pantoprazole—Flushing—Cisplatin—esophageal cancer	0.000174	0.002	CcSEcCtD
Pantoprazole—Abdominal distension—Capecitabine—esophageal cancer	0.000173	0.00199	CcSEcCtD
Pantoprazole—Influenza—Capecitabine—esophageal cancer	0.000172	0.00198	CcSEcCtD
Pantoprazole—Asthma—Capecitabine—esophageal cancer	0.000172	0.00198	CcSEcCtD
Pantoprazole—Dysphagia—Capecitabine—esophageal cancer	0.000172	0.00198	CcSEcCtD
Pantoprazole—Thrombophlebitis—Methotrexate—esophageal cancer	0.000171	0.00197	CcSEcCtD
Pantoprazole—Diabetes mellitus—Methotrexate—esophageal cancer	0.00017	0.00196	CcSEcCtD
Pantoprazole—Photosensitivity—Methotrexate—esophageal cancer	0.000169	0.00194	CcSEcCtD
Pantoprazole—Immune system disorder—Cisplatin—esophageal cancer	0.000169	0.00194	CcSEcCtD
Pantoprazole—Sweating increased—Capecitabine—esophageal cancer	0.000168	0.00193	CcSEcCtD
Pantoprazole—Angina pectoris—Capecitabine—esophageal cancer	0.000168	0.00193	CcSEcCtD
Pantoprazole—Arrhythmia—Cisplatin—esophageal cancer	0.000167	0.00192	CcSEcCtD
Pantoprazole—Bronchitis—Capecitabine—esophageal cancer	0.000166	0.00191	CcSEcCtD
Pantoprazole—Alopecia—Cisplatin—esophageal cancer	0.000165	0.0019	CcSEcCtD
Pantoprazole—Abdominal discomfort—Capecitabine—esophageal cancer	0.000165	0.0019	CcSEcCtD
Pantoprazole—Hepatic failure—Methotrexate—esophageal cancer	0.000165	0.0019	CcSEcCtD
Pantoprazole—Pancytopenia—Capecitabine—esophageal cancer	0.000164	0.00188	CcSEcCtD
Pantoprazole—Malnutrition—Cisplatin—esophageal cancer	0.000163	0.00187	CcSEcCtD
Pantoprazole—Dysuria—Capecitabine—esophageal cancer	0.000161	0.00185	CcSEcCtD
Pantoprazole—Flatulence—Cisplatin—esophageal cancer	0.00016	0.00185	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00016	0.00184	CcSEcCtD
Pantoprazole—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000157	0.00181	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000157	0.00181	CcSEcCtD
Pantoprazole—Weight increased—Capecitabine—esophageal cancer	0.000157	0.0018	CcSEcCtD
Pantoprazole—Visual disturbance—Methotrexate—esophageal cancer	0.000156	0.0018	CcSEcCtD
Pantoprazole—Muscle spasms—Cisplatin—esophageal cancer	0.000156	0.0018	CcSEcCtD
Pantoprazole—Weight decreased—Capecitabine—esophageal cancer	0.000156	0.00179	CcSEcCtD
Pantoprazole—Hyperglycaemia—Capecitabine—esophageal cancer	0.000155	0.00179	CcSEcCtD
Pantoprazole—Pneumonia—Capecitabine—esophageal cancer	0.000154	0.00178	CcSEcCtD
Pantoprazole—Infestation NOS—Capecitabine—esophageal cancer	0.000154	0.00177	CcSEcCtD
Pantoprazole—Infestation—Capecitabine—esophageal cancer	0.000154	0.00177	CcSEcCtD
Pantoprazole—Vision blurred—Cisplatin—esophageal cancer	0.000153	0.00176	CcSEcCtD
Pantoprazole—Depression—Capecitabine—esophageal cancer	0.000153	0.00176	CcSEcCtD
Pantoprazole—Tremor—Cisplatin—esophageal cancer	0.000152	0.00175	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000152	0.00175	CcSEcCtD
Pantoprazole—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000151	0.00174	CcSEcCtD
Pantoprazole—Ill-defined disorder—Cisplatin—esophageal cancer	0.000151	0.00174	CcSEcCtD
Pantoprazole—Myocardial infarction—Capecitabine—esophageal cancer	0.00015	0.00173	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00015	0.00173	CcSEcCtD
Pantoprazole—Anaemia—Cisplatin—esophageal cancer	0.00015	0.00173	CcSEcCtD
Pantoprazole—Stomatitis—Capecitabine—esophageal cancer	0.00015	0.00172	CcSEcCtD
Pantoprazole—Jaundice—Capecitabine—esophageal cancer	0.00015	0.00172	CcSEcCtD
Pantoprazole—Urinary tract infection—Capecitabine—esophageal cancer	0.000149	0.00172	CcSEcCtD
Pantoprazole—Conjunctivitis—Capecitabine—esophageal cancer	0.000149	0.00172	CcSEcCtD
Pantoprazole—Osteoarthritis—Methotrexate—esophageal cancer	0.000148	0.00171	CcSEcCtD
Pantoprazole—Malaise—Cisplatin—esophageal cancer	0.000147	0.00169	CcSEcCtD
Pantoprazole—Haematuria—Capecitabine—esophageal cancer	0.000146	0.00168	CcSEcCtD
Pantoprazole—Leukopenia—Cisplatin—esophageal cancer	0.000146	0.00168	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000145	0.00167	CcSEcCtD
Pantoprazole—Epistaxis—Capecitabine—esophageal cancer	0.000145	0.00167	CcSEcCtD
Pantoprazole—Agranulocytosis—Capecitabine—esophageal cancer	0.000143	0.00165	CcSEcCtD
Pantoprazole—Convulsion—Cisplatin—esophageal cancer	0.000141	0.00162	CcSEcCtD
Pantoprazole—Mood swings—Methotrexate—esophageal cancer	0.00014	0.00162	CcSEcCtD
Pantoprazole—Myalgia—Cisplatin—esophageal cancer	0.000139	0.00159	CcSEcCtD
Pantoprazole—Haemoglobin—Capecitabine—esophageal cancer	0.000139	0.00159	CcSEcCtD
Pantoprazole—Rhinitis—Capecitabine—esophageal cancer	0.000138	0.00159	CcSEcCtD
Pantoprazole—Anxiety—Cisplatin—esophageal cancer	0.000138	0.00159	CcSEcCtD
Pantoprazole—Hepatitis—Capecitabine—esophageal cancer	0.000138	0.00159	CcSEcCtD
Pantoprazole—Haemorrhage—Capecitabine—esophageal cancer	0.000138	0.00159	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000138	0.00158	CcSEcCtD
Pantoprazole—Hypoaesthesia—Capecitabine—esophageal cancer	0.000137	0.00158	CcSEcCtD
Pantoprazole—Liver function test abnormal—Methotrexate—esophageal cancer	0.000137	0.00158	CcSEcCtD
Pantoprazole—Discomfort—Cisplatin—esophageal cancer	0.000137	0.00158	CcSEcCtD
Pantoprazole—Pharyngitis—Capecitabine—esophageal cancer	0.000137	0.00157	CcSEcCtD
Pantoprazole—Urinary tract disorder—Capecitabine—esophageal cancer	0.000136	0.00157	CcSEcCtD
Pantoprazole—Oedema peripheral—Capecitabine—esophageal cancer	0.000136	0.00156	CcSEcCtD
Pantoprazole—Connective tissue disorder—Capecitabine—esophageal cancer	0.000135	0.00156	CcSEcCtD
Pantoprazole—Urethral disorder—Capecitabine—esophageal cancer	0.000135	0.00155	CcSEcCtD
Pantoprazole—Breast disorder—Methotrexate—esophageal cancer	0.000134	0.00154	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000134	0.00154	CcSEcCtD
Pantoprazole—Oedema—Cisplatin—esophageal cancer	0.000133	0.00153	CcSEcCtD
Pantoprazole—Anaphylactic shock—Cisplatin—esophageal cancer	0.000133	0.00153	CcSEcCtD
Pantoprazole—Visual impairment—Capecitabine—esophageal cancer	0.000133	0.00153	CcSEcCtD
Pantoprazole—Infection—Cisplatin—esophageal cancer	0.000132	0.00152	CcSEcCtD
Pantoprazole—Omeprazole—ABCB1—esophageal cancer	0.000131	0.0219	CrCbGaD
Pantoprazole—Erythema multiforme—Capecitabine—esophageal cancer	0.00013	0.0015	CcSEcCtD
Pantoprazole—Nervous system disorder—Cisplatin—esophageal cancer	0.00013	0.0015	CcSEcCtD
Pantoprazole—Thrombocytopenia—Cisplatin—esophageal cancer	0.00013	0.0015	CcSEcCtD
Pantoprazole—Tachycardia—Cisplatin—esophageal cancer	0.00013	0.00149	CcSEcCtD
Pantoprazole—Skin disorder—Cisplatin—esophageal cancer	0.000129	0.00148	CcSEcCtD
Pantoprazole—Eye disorder—Capecitabine—esophageal cancer	0.000129	0.00148	CcSEcCtD
Pantoprazole—Tinnitus—Capecitabine—esophageal cancer	0.000128	0.00148	CcSEcCtD
Pantoprazole—Hyperhidrosis—Cisplatin—esophageal cancer	0.000128	0.00148	CcSEcCtD
Pantoprazole—Asthma—Methotrexate—esophageal cancer	0.000128	0.00147	CcSEcCtD
Pantoprazole—Flushing—Capecitabine—esophageal cancer	0.000128	0.00147	CcSEcCtD
Pantoprazole—ABCB1—lymph node—esophageal cancer	0.000128	0.00251	CbGeAlD
Pantoprazole—Eosinophilia—Methotrexate—esophageal cancer	0.000127	0.00146	CcSEcCtD
Pantoprazole—Anorexia—Cisplatin—esophageal cancer	0.000127	0.00146	CcSEcCtD
Pantoprazole—Pancreatitis—Methotrexate—esophageal cancer	0.000126	0.00145	CcSEcCtD
Pantoprazole—Immune system disorder—Capecitabine—esophageal cancer	0.000124	0.00143	CcSEcCtD
Pantoprazole—Hypotension—Cisplatin—esophageal cancer	0.000124	0.00143	CcSEcCtD
Pantoprazole—Chills—Capecitabine—esophageal cancer	0.000124	0.00142	CcSEcCtD
Pantoprazole—Arrhythmia—Capecitabine—esophageal cancer	0.000123	0.00142	CcSEcCtD
Pantoprazole—Abdominal discomfort—Methotrexate—esophageal cancer	0.000123	0.00141	CcSEcCtD
Pantoprazole—Alopecia—Capecitabine—esophageal cancer	0.000122	0.0014	CcSEcCtD
Pantoprazole—Pancytopenia—Methotrexate—esophageal cancer	0.000122	0.0014	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000121	0.00139	CcSEcCtD
Pantoprazole—Mental disorder—Capecitabine—esophageal cancer	0.000121	0.00139	CcSEcCtD
Pantoprazole—Lansoprazole—ABCB1—esophageal cancer	0.00012	0.02	CrCbGaD
Pantoprazole—Malnutrition—Capecitabine—esophageal cancer	0.00012	0.00138	CcSEcCtD
Pantoprazole—Dysuria—Methotrexate—esophageal cancer	0.00012	0.00138	CcSEcCtD
Pantoprazole—Paraesthesia—Cisplatin—esophageal cancer	0.000119	0.00137	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000119	0.00137	CcSEcCtD
Pantoprazole—Dyspnoea—Cisplatin—esophageal cancer	0.000118	0.00136	CcSEcCtD
Pantoprazole—Flatulence—Capecitabine—esophageal cancer	0.000118	0.00136	CcSEcCtD
Pantoprazole—Erectile dysfunction—Methotrexate—esophageal cancer	0.000118	0.00136	CcSEcCtD
Pantoprazole—Dysgeusia—Capecitabine—esophageal cancer	0.000117	0.00135	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000117	0.00135	CcSEcCtD
Pantoprazole—Back pain—Capecitabine—esophageal cancer	0.000116	0.00134	CcSEcCtD
Pantoprazole—Decreased appetite—Cisplatin—esophageal cancer	0.000115	0.00133	CcSEcCtD
Pantoprazole—Muscle spasms—Capecitabine—esophageal cancer	0.000115	0.00133	CcSEcCtD
Pantoprazole—Pneumonia—Methotrexate—esophageal cancer	0.000115	0.00132	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000115	0.00132	CcSEcCtD
Pantoprazole—Infestation NOS—Methotrexate—esophageal cancer	0.000114	0.00132	CcSEcCtD
Pantoprazole—Infestation—Methotrexate—esophageal cancer	0.000114	0.00132	CcSEcCtD
Pantoprazole—Depression—Methotrexate—esophageal cancer	0.000114	0.00131	CcSEcCtD
Pantoprazole—Pain—Cisplatin—esophageal cancer	0.000114	0.00131	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000113	0.0013	CcSEcCtD
Pantoprazole—Vision blurred—Capecitabine—esophageal cancer	0.000113	0.0013	CcSEcCtD
Pantoprazole—Tremor—Capecitabine—esophageal cancer	0.000112	0.00129	CcSEcCtD
Pantoprazole—Stomatitis—Methotrexate—esophageal cancer	0.000111	0.00128	CcSEcCtD
Pantoprazole—Ill-defined disorder—Capecitabine—esophageal cancer	0.000111	0.00128	CcSEcCtD
Pantoprazole—Conjunctivitis—Methotrexate—esophageal cancer	0.000111	0.00128	CcSEcCtD
Pantoprazole—Anaemia—Capecitabine—esophageal cancer	0.000111	0.00128	CcSEcCtD
Pantoprazole—Sweating—Methotrexate—esophageal cancer	0.00011	0.00126	CcSEcCtD
Pantoprazole—Feeling abnormal—Cisplatin—esophageal cancer	0.000109	0.00126	CcSEcCtD
Pantoprazole—Haematuria—Methotrexate—esophageal cancer	0.000109	0.00125	CcSEcCtD
Pantoprazole—Malaise—Capecitabine—esophageal cancer	0.000108	0.00124	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000108	0.00124	CcSEcCtD
Pantoprazole—Epistaxis—Methotrexate—esophageal cancer	0.000108	0.00124	CcSEcCtD
Pantoprazole—Vertigo—Capecitabine—esophageal cancer	0.000108	0.00124	CcSEcCtD
Pantoprazole—Syncope—Capecitabine—esophageal cancer	0.000108	0.00124	CcSEcCtD
Pantoprazole—Leukopenia—Capecitabine—esophageal cancer	0.000107	0.00124	CcSEcCtD
Pantoprazole—Agranulocytosis—Methotrexate—esophageal cancer	0.000107	0.00123	CcSEcCtD
Pantoprazole—Palpitations—Capecitabine—esophageal cancer	0.000106	0.00122	CcSEcCtD
Pantoprazole—Loss of consciousness—Capecitabine—esophageal cancer	0.000105	0.00121	CcSEcCtD
Pantoprazole—Body temperature increased—Cisplatin—esophageal cancer	0.000105	0.00121	CcSEcCtD
Pantoprazole—Cough—Capecitabine—esophageal cancer	0.000105	0.0012	CcSEcCtD
Pantoprazole—Hypertension—Capecitabine—esophageal cancer	0.000104	0.00119	CcSEcCtD
Pantoprazole—Haemoglobin—Methotrexate—esophageal cancer	0.000103	0.00119	CcSEcCtD
Pantoprazole—Haemorrhage—Methotrexate—esophageal cancer	0.000103	0.00118	CcSEcCtD
Pantoprazole—Hepatitis—Methotrexate—esophageal cancer	0.000103	0.00118	CcSEcCtD
Pantoprazole—Arthralgia—Capecitabine—esophageal cancer	0.000102	0.00118	CcSEcCtD
Pantoprazole—Chest pain—Capecitabine—esophageal cancer	0.000102	0.00118	CcSEcCtD
Pantoprazole—Myalgia—Capecitabine—esophageal cancer	0.000102	0.00118	CcSEcCtD
Pantoprazole—Pharyngitis—Methotrexate—esophageal cancer	0.000102	0.00117	CcSEcCtD
Pantoprazole—Anxiety—Capecitabine—esophageal cancer	0.000102	0.00117	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000101	0.00117	CcSEcCtD
Pantoprazole—Urinary tract disorder—Methotrexate—esophageal cancer	0.000101	0.00117	CcSEcCtD
Pantoprazole—Discomfort—Capecitabine—esophageal cancer	0.000101	0.00116	CcSEcCtD
Pantoprazole—Urethral disorder—Methotrexate—esophageal cancer	0.000101	0.00116	CcSEcCtD
Pantoprazole—Dry mouth—Capecitabine—esophageal cancer	9.99e-05	0.00115	CcSEcCtD
Pantoprazole—Visual impairment—Methotrexate—esophageal cancer	9.89e-05	0.00114	CcSEcCtD
Pantoprazole—Confusional state—Capecitabine—esophageal cancer	9.87e-05	0.00114	CcSEcCtD
Pantoprazole—Oedema—Capecitabine—esophageal cancer	9.79e-05	0.00113	CcSEcCtD
Pantoprazole—Hypersensitivity—Cisplatin—esophageal cancer	9.79e-05	0.00113	CcSEcCtD
Pantoprazole—Infection—Capecitabine—esophageal cancer	9.73e-05	0.00112	CcSEcCtD
Pantoprazole—Erythema multiforme—Methotrexate—esophageal cancer	9.7e-05	0.00112	CcSEcCtD
Pantoprazole—Shock—Capecitabine—esophageal cancer	9.63e-05	0.00111	CcSEcCtD
Pantoprazole—Nervous system disorder—Capecitabine—esophageal cancer	9.6e-05	0.0011	CcSEcCtD
Pantoprazole—Eye disorder—Methotrexate—esophageal cancer	9.59e-05	0.0011	CcSEcCtD
Pantoprazole—Thrombocytopenia—Capecitabine—esophageal cancer	9.59e-05	0.0011	CcSEcCtD
Pantoprazole—Tinnitus—Methotrexate—esophageal cancer	9.57e-05	0.0011	CcSEcCtD
Pantoprazole—Tachycardia—Capecitabine—esophageal cancer	9.56e-05	0.0011	CcSEcCtD
Pantoprazole—Asthenia—Cisplatin—esophageal cancer	9.53e-05	0.0011	CcSEcCtD
Pantoprazole—Skin disorder—Capecitabine—esophageal cancer	9.51e-05	0.00109	CcSEcCtD
Pantoprazole—Hyperhidrosis—Capecitabine—esophageal cancer	9.47e-05	0.00109	CcSEcCtD
Pantoprazole—Anorexia—Capecitabine—esophageal cancer	9.33e-05	0.00107	CcSEcCtD
Pantoprazole—Immune system disorder—Methotrexate—esophageal cancer	9.27e-05	0.00107	CcSEcCtD
Pantoprazole—Chills—Methotrexate—esophageal cancer	9.21e-05	0.00106	CcSEcCtD
Pantoprazole—Hypotension—Capecitabine—esophageal cancer	9.15e-05	0.00105	CcSEcCtD
Pantoprazole—Diarrhoea—Cisplatin—esophageal cancer	9.09e-05	0.00105	CcSEcCtD
Pantoprazole—Alopecia—Methotrexate—esophageal cancer	9.07e-05	0.00104	CcSEcCtD
Pantoprazole—Mental disorder—Methotrexate—esophageal cancer	8.99e-05	0.00103	CcSEcCtD
Pantoprazole—Malnutrition—Methotrexate—esophageal cancer	8.93e-05	0.00103	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Capecitabine—esophageal cancer	8.92e-05	0.00103	CcSEcCtD
Pantoprazole—Insomnia—Capecitabine—esophageal cancer	8.86e-05	0.00102	CcSEcCtD
Pantoprazole—Paraesthesia—Capecitabine—esophageal cancer	8.79e-05	0.00101	CcSEcCtD
Pantoprazole—Dysgeusia—Methotrexate—esophageal cancer	8.75e-05	0.00101	CcSEcCtD
Pantoprazole—Dyspnoea—Capecitabine—esophageal cancer	8.73e-05	0.001	CcSEcCtD
Pantoprazole—Back pain—Methotrexate—esophageal cancer	8.64e-05	0.000994	CcSEcCtD
Pantoprazole—Dyspepsia—Capecitabine—esophageal cancer	8.62e-05	0.000992	CcSEcCtD
Pantoprazole—Decreased appetite—Capecitabine—esophageal cancer	8.51e-05	0.000979	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Capecitabine—esophageal cancer	8.45e-05	0.000973	CcSEcCtD
Pantoprazole—Vomiting—Cisplatin—esophageal cancer	8.45e-05	0.000972	CcSEcCtD
Pantoprazole—Fatigue—Capecitabine—esophageal cancer	8.44e-05	0.000971	CcSEcCtD
Pantoprazole—Vision blurred—Methotrexate—esophageal cancer	8.42e-05	0.000968	CcSEcCtD
Pantoprazole—Rash—Cisplatin—esophageal cancer	8.37e-05	0.000964	CcSEcCtD
Pantoprazole—Pain—Capecitabine—esophageal cancer	8.37e-05	0.000963	CcSEcCtD
Pantoprazole—Constipation—Capecitabine—esophageal cancer	8.37e-05	0.000963	CcSEcCtD
Pantoprazole—Dermatitis—Cisplatin—esophageal cancer	8.37e-05	0.000963	CcSEcCtD
Pantoprazole—Ill-defined disorder—Methotrexate—esophageal cancer	8.29e-05	0.000953	CcSEcCtD
Pantoprazole—Anaemia—Methotrexate—esophageal cancer	8.25e-05	0.00095	CcSEcCtD
Pantoprazole—Feeling abnormal—Capecitabine—esophageal cancer	8.07e-05	0.000928	CcSEcCtD
Pantoprazole—Malaise—Methotrexate—esophageal cancer	8.05e-05	0.000927	CcSEcCtD
Pantoprazole—Vertigo—Methotrexate—esophageal cancer	8.02e-05	0.000923	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Capecitabine—esophageal cancer	8.01e-05	0.000921	CcSEcCtD
Pantoprazole—Leukopenia—Methotrexate—esophageal cancer	7.99e-05	0.00092	CcSEcCtD
Pantoprazole—Nausea—Cisplatin—esophageal cancer	7.89e-05	0.000908	CcSEcCtD
Pantoprazole—Cough—Methotrexate—esophageal cancer	7.79e-05	0.000897	CcSEcCtD
Pantoprazole—Urticaria—Capecitabine—esophageal cancer	7.78e-05	0.000895	CcSEcCtD
Pantoprazole—Body temperature increased—Capecitabine—esophageal cancer	7.74e-05	0.000891	CcSEcCtD
Pantoprazole—Abdominal pain—Capecitabine—esophageal cancer	7.74e-05	0.000891	CcSEcCtD
Pantoprazole—Convulsion—Methotrexate—esophageal cancer	7.74e-05	0.00089	CcSEcCtD
Pantoprazole—Myalgia—Methotrexate—esophageal cancer	7.6e-05	0.000875	CcSEcCtD
Pantoprazole—Chest pain—Methotrexate—esophageal cancer	7.6e-05	0.000875	CcSEcCtD
Pantoprazole—Arthralgia—Methotrexate—esophageal cancer	7.6e-05	0.000875	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	7.55e-05	0.000869	CcSEcCtD
Pantoprazole—Discomfort—Methotrexate—esophageal cancer	7.51e-05	0.000864	CcSEcCtD
Pantoprazole—Confusional state—Methotrexate—esophageal cancer	7.35e-05	0.000846	CcSEcCtD
Pantoprazole—Anaphylactic shock—Methotrexate—esophageal cancer	7.29e-05	0.000839	CcSEcCtD
Pantoprazole—Infection—Methotrexate—esophageal cancer	7.24e-05	0.000833	CcSEcCtD
Pantoprazole—Hypersensitivity—Capecitabine—esophageal cancer	7.21e-05	0.00083	CcSEcCtD
Pantoprazole—Nervous system disorder—Methotrexate—esophageal cancer	7.15e-05	0.000822	CcSEcCtD
Pantoprazole—Thrombocytopenia—Methotrexate—esophageal cancer	7.14e-05	0.000821	CcSEcCtD
Pantoprazole—Skin disorder—Methotrexate—esophageal cancer	7.08e-05	0.000815	CcSEcCtD
Pantoprazole—Hyperhidrosis—Methotrexate—esophageal cancer	7.05e-05	0.000811	CcSEcCtD
Pantoprazole—Asthenia—Capecitabine—esophageal cancer	7.02e-05	0.000808	CcSEcCtD
Pantoprazole—Anorexia—Methotrexate—esophageal cancer	6.95e-05	0.000799	CcSEcCtD
Pantoprazole—Pruritus—Capecitabine—esophageal cancer	6.93e-05	0.000797	CcSEcCtD
Pantoprazole—Hypotension—Methotrexate—esophageal cancer	6.81e-05	0.000784	CcSEcCtD
Pantoprazole—Diarrhoea—Capecitabine—esophageal cancer	6.7e-05	0.000771	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Methotrexate—esophageal cancer	6.64e-05	0.000764	CcSEcCtD
Pantoprazole—Insomnia—Methotrexate—esophageal cancer	6.59e-05	0.000759	CcSEcCtD
Pantoprazole—Paraesthesia—Methotrexate—esophageal cancer	6.54e-05	0.000753	CcSEcCtD
Pantoprazole—Dyspnoea—Methotrexate—esophageal cancer	6.5e-05	0.000748	CcSEcCtD
Pantoprazole—Somnolence—Methotrexate—esophageal cancer	6.48e-05	0.000746	CcSEcCtD
Pantoprazole—Dizziness—Capecitabine—esophageal cancer	6.47e-05	0.000745	CcSEcCtD
Pantoprazole—Dyspepsia—Methotrexate—esophageal cancer	6.42e-05	0.000738	CcSEcCtD
Pantoprazole—Decreased appetite—Methotrexate—esophageal cancer	6.34e-05	0.000729	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Methotrexate—esophageal cancer	6.29e-05	0.000724	CcSEcCtD
Pantoprazole—Fatigue—Methotrexate—esophageal cancer	6.28e-05	0.000723	CcSEcCtD
Pantoprazole—Pain—Methotrexate—esophageal cancer	6.23e-05	0.000717	CcSEcCtD
Pantoprazole—Vomiting—Capecitabine—esophageal cancer	6.23e-05	0.000716	CcSEcCtD
Pantoprazole—Rash—Capecitabine—esophageal cancer	6.17e-05	0.00071	CcSEcCtD
Pantoprazole—Dermatitis—Capecitabine—esophageal cancer	6.17e-05	0.00071	CcSEcCtD
Pantoprazole—Headache—Capecitabine—esophageal cancer	6.13e-05	0.000706	CcSEcCtD
Pantoprazole—Feeling abnormal—Methotrexate—esophageal cancer	6.01e-05	0.000691	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Methotrexate—esophageal cancer	5.96e-05	0.000686	CcSEcCtD
Pantoprazole—Nausea—Capecitabine—esophageal cancer	5.82e-05	0.000669	CcSEcCtD
Pantoprazole—Urticaria—Methotrexate—esophageal cancer	5.79e-05	0.000666	CcSEcCtD
Pantoprazole—Abdominal pain—Methotrexate—esophageal cancer	5.76e-05	0.000663	CcSEcCtD
Pantoprazole—Body temperature increased—Methotrexate—esophageal cancer	5.76e-05	0.000663	CcSEcCtD
Pantoprazole—Hypersensitivity—Methotrexate—esophageal cancer	5.37e-05	0.000618	CcSEcCtD
Pantoprazole—Asthenia—Methotrexate—esophageal cancer	5.23e-05	0.000602	CcSEcCtD
Pantoprazole—Pruritus—Methotrexate—esophageal cancer	5.16e-05	0.000593	CcSEcCtD
Pantoprazole—Diarrhoea—Methotrexate—esophageal cancer	4.99e-05	0.000574	CcSEcCtD
Pantoprazole—Dizziness—Methotrexate—esophageal cancer	4.82e-05	0.000555	CcSEcCtD
Pantoprazole—Vomiting—Methotrexate—esophageal cancer	4.63e-05	0.000533	CcSEcCtD
Pantoprazole—Rash—Methotrexate—esophageal cancer	4.6e-05	0.000529	CcSEcCtD
Pantoprazole—Dermatitis—Methotrexate—esophageal cancer	4.59e-05	0.000528	CcSEcCtD
Pantoprazole—Headache—Methotrexate—esophageal cancer	4.57e-05	0.000525	CcSEcCtD
Pantoprazole—Nausea—Methotrexate—esophageal cancer	4.33e-05	0.000498	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism—ALDOB—esophageal cancer	2.02e-05	0.00033	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	1.98e-05	0.000324	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—BLVRB—esophageal cancer	1.97e-05	0.000322	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC52A3—esophageal cancer	1.97e-05	0.000322	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	1.96e-05	0.00032	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTO1—esophageal cancer	1.95e-05	0.000319	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—TPI1—esophageal cancer	1.95e-05	0.000319	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GAPDH—esophageal cancer	1.95e-05	0.000318	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	1.94e-05	0.000316	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	1.93e-05	0.000315	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CRABP1—esophageal cancer	1.93e-05	0.000315	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—BLVRB—esophageal cancer	1.93e-05	0.000314	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC52A3—esophageal cancer	1.93e-05	0.000314	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALDOB—esophageal cancer	1.87e-05	0.000306	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GNG7—esophageal cancer	1.83e-05	0.000299	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GAPDH—esophageal cancer	1.8e-05	0.000294	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—BLVRB—esophageal cancer	1.8e-05	0.000294	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC52A3—esophageal cancer	1.8e-05	0.000294	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CRABP1—esophageal cancer	1.79e-05	0.000292	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.76e-05	0.000288	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	1.73e-05	0.000283	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ALDH2—esophageal cancer	1.72e-05	0.000281	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GNG7—esophageal cancer	1.7e-05	0.000277	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC10A2—esophageal cancer	1.68e-05	0.000274	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CA1—esophageal cancer	1.68e-05	0.000274	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	1.66e-05	0.000272	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC10A2—esophageal cancer	1.64e-05	0.000267	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CA1—esophageal cancer	1.64e-05	0.000267	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTT1—esophageal cancer	1.63e-05	0.000267	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	1.62e-05	0.000264	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP2A6—esophageal cancer	1.62e-05	0.000264	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.61e-05	0.000263	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.61e-05	0.000263	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALDH2—esophageal cancer	1.59e-05	0.00026	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.58e-05	0.000258	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC52A3—esophageal cancer	1.54e-05	0.000251	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—BLVRB—esophageal cancer	1.54e-05	0.000251	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CA2—esophageal cancer	1.53e-05	0.000251	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS1—esophageal cancer	1.53e-05	0.00025	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ENO1—esophageal cancer	1.53e-05	0.00025	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.53e-05	0.00025	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CA1—esophageal cancer	1.53e-05	0.00025	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.53e-05	0.00025	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTT1—esophageal cancer	1.51e-05	0.000247	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PSME2—esophageal cancer	1.51e-05	0.000246	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PSME1—esophageal cancer	1.51e-05	0.000246	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.5e-05	0.000245	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CA2—esophageal cancer	1.5e-05	0.000245	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP2A6—esophageal cancer	1.5e-05	0.000244	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.43e-05	0.000233	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PLCE1—esophageal cancer	1.43e-05	0.000233	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ADH7—esophageal cancer	1.43e-05	0.000233	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS1—esophageal cancer	1.42e-05	0.000232	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ENO1—esophageal cancer	1.42e-05	0.000232	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.42e-05	0.000231	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.41e-05	0.00023	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CA2—esophageal cancer	1.4e-05	0.000228	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PSME1—esophageal cancer	1.4e-05	0.000228	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PSME2—esophageal cancer	1.4e-05	0.000228	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PLCE1—esophageal cancer	1.39e-05	0.000227	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ADH7—esophageal cancer	1.39e-05	0.000227	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.38e-05	0.000226	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.37e-05	0.000224	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.37e-05	0.000223	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.32e-05	0.000215	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.31e-05	0.000215	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC10A2—esophageal cancer	1.31e-05	0.000213	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CA1—esophageal cancer	1.31e-05	0.000213	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	1.3e-05	0.000213	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.3e-05	0.000212	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ADH7—esophageal cancer	1.3e-05	0.000212	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.29e-05	0.00021	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.25e-05	0.000204	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	1.22e-05	0.0002	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ADH1B—esophageal cancer	1.22e-05	0.000199	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP1B1—esophageal cancer	1.21e-05	0.000197	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CA2—esophageal cancer	1.2e-05	0.000195	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—TYMP—esophageal cancer	1.2e-05	0.000195	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.19e-05	0.000195	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.19e-05	0.000194	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.19e-05	0.000194	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.17e-05	0.000191	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—TYMP—esophageal cancer	1.17e-05	0.000191	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.16e-05	0.00019	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.14e-05	0.000187	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.14e-05	0.000186	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.14e-05	0.000185	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP19A1—esophageal cancer	1.13e-05	0.000185	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.13e-05	0.000185	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.12e-05	0.000183	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—HMOX1—esophageal cancer	1.12e-05	0.000182	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.11e-05	0.000182	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ADH7—esophageal cancer	1.11e-05	0.000182	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALOX15—esophageal cancer	1.11e-05	0.000181	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.1e-05	0.000179	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.1e-05	0.000179	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TYMP—esophageal cancer	1.09e-05	0.000178	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—TPI1—esophageal cancer	1.08e-05	0.000177	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.08e-05	0.000177	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ABCB1—esophageal cancer	1.07e-05	0.000175	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.06e-05	0.000173	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTO1—esophageal cancer	1.06e-05	0.000172	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—TPI1—esophageal cancer	1.06e-05	0.000172	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.04e-05	0.000169	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—HMOX1—esophageal cancer	1.03e-05	0.000169	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.03e-05	0.000169	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALDOB—esophageal cancer	1.01e-05	0.000165	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CA1—esophageal cancer	1.01e-05	0.000165	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.01e-05	0.000165	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GAPDH—esophageal cancer	9.98e-06	0.000163	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ABCB1—esophageal cancer	9.93e-06	0.000162	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CRABP1—esophageal cancer	9.89e-06	0.000161	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTO1—esophageal cancer	9.86e-06	0.000161	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TPI1—esophageal cancer	9.86e-06	0.000161	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ADH1B—esophageal cancer	9.75e-06	0.000159	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GAPDH—esophageal cancer	9.74e-06	0.000159	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	9.72e-06	0.000159	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CRABP1—esophageal cancer	9.65e-06	0.000158	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALDOB—esophageal cancer	9.45e-06	0.000154	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GNG7—esophageal cancer	9.4e-06	0.000154	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	9.4e-06	0.000154	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TYMP—esophageal cancer	9.31e-06	0.000152	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CA2—esophageal cancer	9.23e-06	0.000151	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GNG7—esophageal cancer	9.18e-06	0.00015	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GAPDH—esophageal cancer	9.1e-06	0.000149	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP26A1—esophageal cancer	9.06e-06	0.000148	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.02e-06	0.000147	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALOX15—esophageal cancer	8.83e-06	0.000144	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALDH2—esophageal cancer	8.81e-06	0.000144	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALDH2—esophageal cancer	8.6e-06	0.00014	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ADH7—esophageal cancer	8.58e-06	0.00014	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.58e-06	0.00014	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GNG7—esophageal cancer	8.58e-06	0.00014	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTO1—esophageal cancer	8.42e-06	0.000138	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TPI1—esophageal cancer	8.42e-06	0.000138	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTT1—esophageal cancer	8.38e-06	0.000137	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP2A6—esophageal cancer	8.29e-06	0.000135	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.25e-06	0.000135	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTT1—esophageal cancer	8.18e-06	0.000134	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.11e-06	0.000132	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP2A6—esophageal cancer	8.09e-06	0.000132	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALDOB—esophageal cancer	8.08e-06	0.000132	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.04e-06	0.000131	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ENO1—esophageal cancer	7.85e-06	0.000128	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS1—esophageal cancer	7.85e-06	0.000128	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GAPDH—esophageal cancer	7.77e-06	0.000127	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PSME1—esophageal cancer	7.74e-06	0.000126	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PSME2—esophageal cancer	7.74e-06	0.000126	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CRABP1—esophageal cancer	7.7e-06	0.000126	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS1—esophageal cancer	7.67e-06	0.000125	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ENO1—esophageal cancer	7.67e-06	0.000125	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.66e-06	0.000125	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTT1—esophageal cancer	7.64e-06	0.000125	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.56e-06	0.000123	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PSME2—esophageal cancer	7.55e-06	0.000123	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PSME1—esophageal cancer	7.55e-06	0.000123	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.53e-06	0.000123	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.52e-06	0.000123	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GNG7—esophageal cancer	7.33e-06	0.00012	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TYMP—esophageal cancer	7.19e-06	0.000117	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CREBBP—esophageal cancer	7.17e-06	0.000117	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ENO1—esophageal cancer	7.16e-06	0.000117	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.16e-06	0.000117	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PSME1—esophageal cancer	7.06e-06	0.000115	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PSME2—esophageal cancer	7.06e-06	0.000115	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.99e-06	0.000114	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALDH2—esophageal cancer	6.87e-06	0.000112	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.81e-06	0.000111	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.76e-06	0.00011	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1B1—esophageal cancer	6.68e-06	0.000109	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CREBBP—esophageal cancer	6.64e-06	0.000108	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTT1—esophageal cancer	6.53e-06	0.000107	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1B1—esophageal cancer	6.52e-06	0.000106	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TPI1—esophageal cancer	6.5e-06	0.000106	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.5e-06	0.000106	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP2A6—esophageal cancer	6.46e-06	0.000105	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.43e-06	0.000105	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—NOS3—esophageal cancer	6.42e-06	0.000105	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP19A1—esophageal cancer	6.28e-06	0.000103	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.23e-06	0.000102	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.16e-06	0.000101	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP19A1—esophageal cancer	6.13e-06	0.0001	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS1—esophageal cancer	6.12e-06	9.99e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ENO1—esophageal cancer	6.12e-06	9.99e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.09e-06	9.95e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PSME2—esophageal cancer	6.03e-06	9.85e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PSME1—esophageal cancer	6.03e-06	9.85e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GAPDH—esophageal cancer	6e-06	9.8e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.95e-06	9.71e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—NOS3—esophageal cancer	5.94e-06	9.7e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS2—esophageal cancer	5.87e-06	9.58e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HMOX1—esophageal cancer	5.73e-06	9.36e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP19A1—esophageal cancer	5.73e-06	9.35e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GNG7—esophageal cancer	5.66e-06	9.24e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.62e-06	9.18e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HMOX1—esophageal cancer	5.59e-06	9.13e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ABCB1—esophageal cancer	5.5e-06	8.98e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS2—esophageal cancer	5.43e-06	8.87e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.3e-06	8.65e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.27e-06	8.6e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.22e-06	8.53e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP1B1—esophageal cancer	5.2e-06	8.5e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.13e-06	8.37e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.04e-06	8.23e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.02e-06	8.19e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.98e-06	8.14e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP19A1—esophageal cancer	4.89e-06	7.99e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—EP300—esophageal cancer	4.88e-06	7.97e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ENO1—esophageal cancer	4.72e-06	7.71e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.72e-06	7.71e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PSME1—esophageal cancer	4.65e-06	7.6e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PSME2—esophageal cancer	4.65e-06	7.6e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—EP300—esophageal cancer	4.52e-06	7.38e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HMOX1—esophageal cancer	4.46e-06	7.29e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.38e-06	7.15e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCB1—esophageal cancer	4.29e-06	7e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.16e-06	6.79e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.02e-06	6.56e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.79e-06	6.19e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.78e-06	6.17e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.68e-06	6e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	3.61e-06	5.9e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CREBBP—esophageal cancer	3.59e-06	5.86e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.45e-06	5.63e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.35e-06	5.47e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—esophageal cancer	3.34e-06	5.46e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.31e-06	5.4e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NOS3—esophageal cancer	3.29e-06	5.37e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.24e-06	5.29e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NOS3—esophageal cancer	3.21e-06	5.25e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS2—esophageal cancer	3.01e-06	4.92e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NOS3—esophageal cancer	3e-06	4.9e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS2—esophageal cancer	2.94e-06	4.8e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.86e-06	4.68e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.74e-06	4.48e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NOS3—esophageal cancer	2.56e-06	4.19e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—EP300—esophageal cancer	2.5e-06	4.09e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—EP300—esophageal cancer	2.44e-06	3.99e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.35e-06	3.83e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—EP300—esophageal cancer	2.28e-06	3.73e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.21e-06	3.61e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NOS3—esophageal cancer	1.98e-06	3.23e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—EP300—esophageal cancer	1.95e-06	3.19e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.85e-06	3.02e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.81e-06	2.96e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.81e-06	2.95e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.69e-06	2.76e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—EP300—esophageal cancer	1.51e-06	2.46e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.44e-06	2.36e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.11e-06	1.82e-05	CbGpPWpGaD
